tradingkey.logo

10X Genomics Inc

TXG
View Detailed Chart

13.840USD

+0.740+5.65%
Market hours ETQuotes delayed by 15 min
1.72BMarket Cap
LossP/E TTM

10X Genomics Inc

13.840

+0.740+5.65%
Intraday
1m
30m
1h
D
W
M
D

Today

+5.65%

5 Days

+4.53%

1 Month

+19.93%

6 Months

+26.97%

Year to Date

-3.62%

1 Year

-39.85%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 18 analysts
BUY
Current Rating
15.000
Target Price
12.28%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

117
Total
7
Median
9
Average
Company name
Ratings
Analysts
10X Genomics Inc
TXG
18
Medtronic PLC
MDT
35
Stryker Corp
SYK
33
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
30
Dexcom Inc
DXCM
28
1
2
3
...
24

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Buy
Sell(2)
Neutral(5)
Buy(6)
Indicators
Sell(2)
Neutral(5)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.112
Neutral
RSI(14)
51.633
Neutral
STOCH(KDJ)(9,3,3)
52.597
Neutral
ATR(14)
0.868
Low Volatility
CCI(14)
5.030
Neutral
Williams %R
53.257
Neutral
TRIX(12,20)
0.175
Sell
StochRSI(14)
0.000
Sell
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
13.338
Buy
MA10
13.091
Buy
MA20
13.328
Buy
MA50
12.465
Buy
MA100
10.537
Buy
MA200
12.093
Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for analyzing biological systems. Its Chromium platform includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Chromium Single Cell Multiome ATAC + Gene Expression, Visium Spatial Gene Expression, and others.
Ticker SymbolTXG
Company10X Genomics Inc
CEOMr. Serge Wilson Saxonov, Ph.D.
Websitehttps://www.10xgenomics.com/
KeyAI